MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.
about
MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
MYCN contributes to the malign ...... epigenetic repression of p21.
@en
MYCN contributes to the malign ...... epigenetic repression of p21.
@nl
type
label
MYCN contributes to the malign ...... epigenetic repression of p21.
@en
MYCN contributes to the malign ...... epigenetic repression of p21.
@nl
prefLabel
MYCN contributes to the malign ...... epigenetic repression of p21.
@en
MYCN contributes to the malign ...... epigenetic repression of p21.
@nl
P2093
P2860
P356
P1476
MYCN contributes to the malign ...... epigenetic repression of p21.
@en
P2093
Chun-Kang Chang
Ling-Yun Wu
Zheng Zhang
P2860
P2888
P356
10.1038/CDDIS.2017.526
P577
2017-10-12T00:00:00Z
P6179
1092186449